18th Annual Conference of BHIVA - Poster Presentations >

18th Annual Conference - Poster Presentations: Co-infections, Opportunistic Infections and Sexually Transmitted Infections (P91 - P111)

P91 Screening for latent TB infection in HIV positive patients: can this be done?
S Dakshina1, D Macallan2 and C McCormick1
1Courtyard Clinic, St George's Hospital, London, UK, 2Clinical Infections Unit, St George's University of London, London, UK

P92 Viral relapse is associated with the emergence of new viral strains following treatment in an HIV-positive cohort infected with acute HCV
T Abdelrahman1, E Bird2, P Karayiannis2, J Main2 and E Thomson1
1University of Glasgow, Centre for Virus Research, Glasgow, UK, 2Imperial College London, London, UK

P93 Is ultrasound an effective screening tool for the diagnosis of hepatocellular carcinoma in patients coinfected with HIV and hepatitis B or hepatitis C? (Poster not yet available)
H Gay, L Raman, C Davies, M Nelson and M Bower
Chelsea and Westminster Hospital, London, UK

P94 Low detection rates of hepatitis delta in Greater Manchester in hepatitis B surface antigen positive patients monoinfected and co-infected with HIV
F Slevin, D Lebari, J Baxter and J Vilar
Monsall Unit, Department of Infectious Diseases, Manchester, UK

P95 Boceprevir for the treatment of chronic hepatitis C in HIV co-infection
A Ahmed, E Page, M Bower and M Nelson
Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

P96 Cost-effectiveness of adult vaccination of HIV-positive individuals with the 13-Valent Pneumococcal Conjugate Vaccine in the United Kingdom (Poster not yet available)
A Charos and P Balmer
Pfizer Ltd, Walton Oaks, UK

P97 Eosinophilia: clinical significance in HIV infected individuals
M Sivaram1, A White2 and K Radcliffe3
1Sandwell and West Birmingham Hospital NHS Trust, Sandwell, West Midlands, UK, 2University of Birmingham, Birmingham, UK, 3Whittall Street Clinic, Birmingham, UK

P98 An investigation into the role of HSV-2 serology in reducing HIV transmission risk behaviour in HIV-infected individuals (Poster not yet available)
O Dosekun, D Axten, H Williams, C Williams, M Desai, CY Tong, A Menon-Johansson and J Fox
Guy's and St.Thomas' NHS Foundation Trust, London, UK

P99 The seroprevalence of hepatitis E virus in HIV positive subjects in a single treatment centre
B Talbot1, D Webster2, S Ijaz3, H Dalton4 and M Fisher1
1Brighton and Sussex University Hospitals, Brighton, UK, 2Brighton and Sussex Medical School, Brighton, UK, 3Health Protection Agency, London, UK, 4Royal Cornwall Hospitals Trust, Truro, UK

P100 The burden of liver disease in HIV/HBV co-infected patients accessing antiretroviral therapy in Ghana: the HEPIK study (Poster not yet available)
L Appiah1, G Foster2, A Cozzi Lepri3, G Dusheiko3, S Bhagani4, D Chadwick5, RO Philipps1, A-M Geretti2 and DO Adinku1
1Komfo Anokye Teaching Hospital, Kumasi, Ghana, 2University of Liverpool, Liverpool, UK, 3University College London, London, UK, 4Royal Free Hospital NHS Trust, London, UK, 5The James Cook University, Middlesbrough, UK

P101 The prevalence of cryptococcal antigenemia in newly diagnosed patients with advanced HIV in an urban UK cohort (Poster not yet available)
S Patel1, GY Shin2, I Wijejewardana3, R Vitharana4, I Cormack4, M Pakianathan1, T Harrison3 and T Bicanic3
1Courtyard Clinic, St George's Hospital, London, UK, 2Department of Virology, St George's Hospital, London, UK, 3St George's University of London, London, UK, 4Croydon University Hospital, London, UK

P102 Use of rifabutin in the treatment of tuberculosis in HIV positive individuals
T Rawson1, S Basnayake2 and A Pozniak2
1Imperial College School of Medicine, London, UK, 2Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

P103 Is testing for latent tuberculosis infection in an UK HIV clinic cost effective?
S Capocci1, C Smith1, S Morris2, S Bhagani1, I Cropley1, M Johnson1 and M Lipman1
1Royal Free Hospital, London, UK, 2University College London, London, UK

P104 Can haemoglobin drop replace rapid virological response in predicting a sustained virological response?
D Awoyemi, S Mandalia, M Bower, M Anderson and M Nelson
Chelsea and Westminster Hospital, London, UK

P105 Audit on clinical management of patients co-infected with HIV and Hepatitis B
L Ceccarelli, S Morris, A Wilson and C Leen
Western General Hospital, Infectious Diseases Unit, Edinburgh, Scotland, UK

P106 Audit of eligibility of hepatitis C/HIV co-infected patients in the Lothian cohort for new HCV protease inhibitor containing regime
KA Devine and C Leen
Western General Hospital, Regional Infectious Diseases Unit, Edinburgh, Lothian, UK

P107 High rates of advanced fibrosis and cirrhosis in HIV/HCV Coinfected patients naïve to HCV treatment in an urban ethnically diverse cohort
K Childs1, J Bayley1, R Byrne2, A Suddle2, K Agarwal2 and C Taylor1
1Department of Sexual Health, King's College Hospital Foundation Trust, London, UK, 2Institute of Liver Studies, King's College Hospital Foundation Trust, London, UK

P108 Abstract withdrawn

P109 A case series of otosyphilis – missed opportunities for early treatment?
D Bradshaw, S Pallawella, M Nelson, C Scott and S Day
Chelsea and Westminster Hospital, London, England

P110 Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals (Poster not yet available)
M Cevik1, L Dickinson2, G Singh1, A Scourfield3 and M Nelson1
1Chelsea and Westminster Hospital, St Stephen's Centre, London, UK, 2Royal Liverpool & Broadgreen University Hospital Trust, Liverpool, UK, 3Brighton and Sussex University Hospital, Brighton, UK

P111 Open TB in an HIV clinic – sharing our experience of a serious untoward incident (Poster not yet available)
C Woodward1, R Miller2, D Mercey1, M Young1 and P Benn1
1Mortimer Market Centre, London, UK, 2University College London Medical School, London, UK